22.64 (-%)
As of Nov 20, 2024
Source:
Nurix Therapeutics, Inc is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of small molecule and cell therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer and other challenging diseases.
Country | United States |
Headquarters | san francisco, california |
Phone Number | (415) 660-5320 |
Industry | manufacturing |
CEO | Arthur T. Sands |
Website | http://www.nurixtx.com |